The following compoundsDrug for treatment and treatment of hypoxemia. The opioid kappa receptor agonist of the present invention is characterized by the nature of a water purifying agent that specifically removes water, and has a sodium retention function that does not link to diuretic action, and is an ideal hypoxemia treatment disorder that can be further ignored It is useful for the pharmacotherapy of hyponatremia.
展开▼